JeanMarie Guenot is not your typical woman. She has worked for more than twenty years in the biotechnology and pharmaceutical industries. Her academic success was obtained when she got an MBA at the University of Pennsylvania and a Ph.D. from the University of California at San Francisco. Throughout her career, she has worked at the executive level of a lot of startups and well-established companies. That work has given her a lot of experience. Her ambition and passion for creating new businesses and making them successful have catapulted her to the highest level of modern business managers as mentioned on businesswire.com. If a person reviews her career, they can see she loves working with new businesses.
Looking at all Ms.Guenot has achieved during her career, it is obvious that she loves starting new businesses. Despite the fact that it may be an impossible task to name all of the businesses she has been employed at, it is important to focus on her major career accomplishments. The first company she worked for was Guenot, LLC.
From 2008 to 2009, JeanMarie Guenot worked for Guenot, LLC. This company that gives consulting services to businesses to biotechnology and pharmaceutical companies. They also provide services such as licensing, mergers and acquisitions, and financing to those industries. Then she went on to found SKS Ocular, LLC.
Between the years of 2009 and 2012, JeanMarie Guenot founded and was the first employee of SKS Ocular, LLC. They are a biotechnology company whose main goal is to treat eye-related issues. At the present time, she is working as the CEO and President of Amphivena Therapeutics, Inc. This company was started in 2012 with the goal of making and manufacturing drugs that can help treat or cure diseases such as leukemia. It is important to know what Amphivena Therapeutics is and what they have accomplished.
In the year of 2013, Amphivena Therapeutics came to an agreement with Janssen Biotech and has found a way to raise over fourteen million dollars to assist in creating better and first-in-class immunotherapy for hematologic malignancies. This type of treatment has been termed by a lot of doctors as a big milestone in assisting to totally getting rid of blood cancer and help people who are at risk to live a long and healthy life. Amphivena has had a lot of success since they started working with Janssen.
Ever since Amphivena and Janssen started working together, their research has been getting better. This has been backed by the Manufacturing Director of MPM Capital, Luke Evnin when he described the process as a new anti-cancer therapy. MPM is the main inventor In Amphivena. Ms. Guenot has been playing the main role in both achievements and management of the success of Amphivena. She has pointed the company in the right direction and has assisted making the company into the success it is today.
Ms.Guenot has achieved a lot of great things academically and career wise. With the wonderful things she has accomplished in her life so far, it is no wonder what wonderful things she will do next.
Learn more about Jeanmarie Guenot: https://www.crunchbase.com/person/jeanmarie-guenot